# U.S. Physical Therapy, Inc. account plan

> U.S. Physical Therapy runs 799 outpatient physical therapy clinics and an industrial injury prevention business, with FY2025 revenue of $781.0 million.

## At a glance

U.S. Physical Therapy (USPH), based in Houston, operates outpatient physical, occupational and speech therapy clinics and home-care practices for orthopedic, sports and work injuries, plus an industrial injury prevention business sold to employers. Clinics run as Clinic Partnerships in which USPH generally holds 65% to 75% and the managing physical therapist owns the rest. FY2025 net revenue was $781.0 million (+16.3%), operating income $86.7 million and net income attributable to USPH shareholders $39.6 million. The company had 780 clinics in 44 states and about 7,294 employees at 31 December 2025, and 799 clinics at 30 September 2026.

## Business units

- **Physical therapy operations** (about 85% of FY2025 net revenue ($666.6 million)): Outpatient PT, OT and speech therapy clinics and home-care practices, paid mainly by managed care/commercial insurers (48.5%), Medicare/Medicaid (35.8%) and workers' compensation (10.2%). Visits rose 14.9% to 6,150,104 in 2025. Since 2026 it also earns hospital affiliation revenue ($25.0 million in Q3 2026) from 72 clinics placed in hospital systems' networks.
- **Industrial injury prevention services (IIP)** (about 15% of FY2025 net revenue ($114.4 million)): Onsite injury prevention and rehabilitation, post-offer employment testing, functional capacity evaluations and ergonomic assessments, contracted mainly by employers including a number of Fortune 500 companies. Briotix Health, about 92% owned, is the main vehicle. Q3 2026 revenue was $33.0 million (+13.8%) at a 21.9% gross margin.

## Strategic priorities

- **Hospital affiliations**: Under two 10-year alliances announced in February 2026, 62 Metro clinics in New York joined the NYU Langone network and 10 clinics joined a Gulf Coast hospital system; all 72 were integrated by the end of Q3 2026. Management is in talks with more hospital systems.
- **Acquisitions of PT and IIP businesses**: USPH keeps buying multi-clinic practices, home-care practices and IIP businesses; 2026 deals include 50% of an eight-clinic practice, 70% of an IIP business and 67% of a twelve-clinic practice.
- **Higher net rate per visit**: Revenue per visit rose to $110.61 in Q3 2026 from $105.54, helped by hospital rates and workers' compensation PPO agreements.
- **Back-office efficiency**: A new ERP for HR and accounting, centralised billing and collections into 2027, and the WelcomeWare front-desk technology rolled out in 420 locations.
- **Digital and hybrid care**: The company is working on its own digital and hybrid offerings for 2027 and has hired a senior leader to find partners.

## Latest results

In Q3 2026 net revenue rose 12.9% to $222.6 million, including $25.0 million of new hospital affiliation revenue; physical therapy revenue was $189.5 million (+12.7%) and IIP revenue $33.0 million (+13.8%). Adjusted EBITDA was $27.8 million (vs $23.9 million), while net income attributable to shareholders fell to $11.0 million from $13.1 million. Visits reached 33.4 per clinic per day. Over nine months revenue was $634.9 million (+9.8%). Full-year 2026 EBITDA guidance of $102 million to $106 million was reaffirmed.

## Investments and deals

- **2026 clinic acquisitions**: Three 2026 deals total $38 million of purchase price, including a 12-clinic practice bought for $16.4 million with $12 million of annual revenue.
- **$450 million credit facility**: A five-year facility closed on 14 April 2026 ($175.0 million term loan and $275.0 million revolver, maturing 14 April 2031); borrowings were $246.6 million at 30 September 2026.
- **Share buybacks and dividend**: 306,256 shares were repurchased for $19.2 million in 2026, nearly completing the $25.0 million authorization; the quarterly dividend is $0.46.
- **Finance and HR systems**: A new finance and HR system implementation, phased over time, with costs expected to continue into 2027.

## Challenges and risks

- **Self-insured health benefit costs**: Employee insurance claims expense was $7 million higher year to date in 2026, about 150 basis points of PT margin headwind in Q3, prompting labour reductions and discretionary spending cuts.
- **Medicare reimbursement**: Medicare therapy rates were cut repeatedly from 2021 to 2025; 2026 brought about 1.75%, which equates to a 1.1% increase after the Medicare Advantage mix.
- **Therapist recruiting and wages**: Workforce costs are the largest operating expense, and a tight labour market makes staffing the constraint on volume.
- **Partner put rights**: Partners' put rights could force purchases of significant equity, and revaluation of redeemable non-controlling interests drove a GAAP loss per share of $1.04 in Q3 2026.
- **Healthcare regulation**: Anti-Kickback, Stark Law, corporate practice of medicine and HIPAA rules apply, including to management and hospital arrangements.

## What leadership says

> "a very significant benefit to us" — Chris Reading, Chairman and CEO, Q3 2026 earnings call, 5 November 2026, on CMS phasing out the IPCI modifier

> "We're in discussion with a great many right now" — Chris Reading, Chairman and CEO, Q3 2026 earnings call, 5 November 2026, on hospital system partnerships

> "we feel confident that 2027 is going to look meaningfully different with the next few of these" — Chris Reading, Chairman and CEO, Q2 2026 earnings call, 6 August 2026

> "we're not going to spend differently just because we have money available" — Chris Reading, Chairman and CEO, Q2 2026 earnings call, 6 August 2026, on M&A


## Where a supplier can help

- **Hospital EMR and integration support**: Moving clinics into hospital networks required staff to learn a new hospital-based EMR; more hospital deals mean more integration, training and data migration work.
- **Employee benefits cost control**: Self-insured health claims running well above average point to stop-loss, benefits administration and care-navigation providers.
- **Clinician recruiting**: Staffing is the constraint on volume, which suits therapist recruiting, staffing and university pipeline partners.
- **Billing, ERP and front-desk automation**: Centralised billing, the new finance and HR system and the WelcomeWare rollout fit revenue-cycle, ERP and patient-intake software vendors.
- **Digital and hybrid care partners**: The plan for digital and hybrid offerings in 2027, with a senior leader hired to find partners, opens a door for virtual PT and remote monitoring providers.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Form 10-K for the fiscal year ended December 31, 2025](https://www.sec.gov/Archives/edgar/data/885978/000114036126007170/ef20060831_10k.htm)

Annual report · 2026-02-27

- U.S. Physical Therapy (USPH, Houston) operates two reportable segments: physical therapy operations (outpatient PT, OT and speech clinics plus home-care practices) and industrial injury prevention services (IIP), contracted mostly by employers including a number of Fortune 500 companies.
- FY2025 net revenue was $781.0 million, up 16.3% from $671.3 million; operating income $86.7 million (vs $63.0 million); net income attributable to USPH shareholders $39.6 million; Adjusted EBITDA $95.0 million (up 16.2% from $81.8 million).
- Physical therapy operations: $666.6 million revenue, 6,150,104 patient visits (up 14.9%), net rate per visit $105.76; IIP: $114.4 million revenue (up 18.0%), gross margin 18.9%.
- 780 clinics in 44 states at 31 December 2025, including 34 hospital- or physician-owned practices managed under contract; about 7,294 employees (about 4,200 full-time).
- Partnership model: clinics are run as Clinic Partnerships in which USPH generally holds 65% to 75% and the managing physical therapist owns the rest, with put and call rights at a predetermined multiple of earnings.
- Strategy: keep acquiring multi-clinic PT practices and home-care practices, open satellite clinics, and buy IIP businesses; 2025 acquisitions included practices in February, April and July plus 14 tuck-in clinics.
- New growth lever: 10-year strategic alliances announced in February 2026 under which 60 Metro clinics in New York and 10 clinics of another partnership join hospital systems' clinical services networks, which the company says will be accretive to revenue, operating income and margins.
- Payor mix of net patient revenue: managed care/commercial 48.5%, Medicare/Medicaid 35.8%, workers' compensation 10.2%; Medicare therapy reimbursement fell in 2025 (the 10-K gives about 1.5% in Item 1 and about 2.9% in MD&A) and is expected to rise about 1.75% in 2026.
- Main risks: Medicare and payor reimbursement, physician referrals, recruiting and retaining therapists amid wage inflation, put-right obligations to partners, fraud-and-abuse/Stark/corporate-practice regulation, cybersecurity.
- Implementing a new ERP for HR and accounting; $325 million Bank of America credit agreement with $161.8 million drawn at year-end; quarterly dividend raised to $0.46 in February 2026.

### [Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/885978/000114036126042104/ef20080638_10q.htm)

Interim report · 2026-11-05

- Q3 2026 net revenue $222.6 million, up 12.9% from $197.1 million; nine-month revenue $634.9 million (+9.8%).
- New revenue line: hospital affiliation revenue of $25.0 million in Q3 ($30.6 million year to date), after all 72 clinics under the two hospital alliances (62 Metro clinics in New York, 10 of another partnership) were integrated by quarter end.
- Physical therapy revenue $189.5 million (+12.7%), mature revenue +6.4%; visits 1,682,642 (+8.3%); revenue per visit $110.61 vs $105.54; 33.4 visits per clinic per day.
- IIP revenue $33.0 million (+13.8%, +8.3% excluding the January 2026 acquisition); IIP gross margin 21.9% vs 19.6%.
- PT gross margin 18.9% (adjusted 19.1%) despite higher self-insured health benefit costs worth about 150 basis points of margin headwind.
- Net income attributable to shareholders $11.0 million (vs $13.1 million); GAAP loss per share $1.04 due to revaluation of redeemable non-controlling interests; Adjusted EBITDA $27.8 million (vs $23.9 million); adjusted EPS $0.80 (vs $0.66).
- 799 clinics at 30 September 2026; 2026 acquisitions: 8-clinic practice (50%), an IIP business (70%) and a 12-clinic practice (67%, July).
- New $450 million credit facility (April 2026, to 2031), borrowings $246.6 million; 306,256 shares repurchased for $19.2 million; Nchacha Etta appointed CFO in September 2026.

### [U.S. Physical Therapy Q3 2026 earnings call transcript](https://www.sec.gov/Archives/edgar/data/885978/000088597826000078/usphq326_110526-transcriptfi.htm)

Executive talk · Chris Reading, Chairman and Chief Executive Officer · 2026-11-05

- CEO Chris Reading (Chairman and CEO) and new CFO Nchacha Etta presented Q3 2026: revenue $223 million (+13%), PT revenue $190 million (+13%), visits up 8%, IIP revenue up 14% with profitability up 27%.
- Volume streak: every month in 2026 has been a record for that month, "27 consecutive months"; visits held above 33 per clinic per day through the summer.
- Hospital affiliations: all Metro New York clinics moved into the NYU Langone relationship and the Gulf Coast Group brought 10 facilities in September; hospital revenue grew from less than 5% in Q2 to over 13% of revenue; 72 clinics converted (62 and 10).
- Net rate per visit rose by more than $5 to $111; September reached $112, an all-time record; workers' comp revenue per visit +8%, Medicare +2%.
- Headwind: self-insured employee health claims $7 million higher year to date; the company made "targeted, very surgical labor reductions" and cut discretionary spending from mid-October.
- Full-year 2026 EBITDA guidance of $102 million to $106 million reaffirmed; quarterly dividend $0.46.
- Reimbursement: the final 2027 fee schedule looks about 0.7% positive at first read, and CMS will phase out the IPCI modifier over two years from 2027, which Reading calls "a very significant benefit to us".
- Pipeline: "in discussion with a great many" hospital systems and expects one or a few more announcements; Metro is "trending nicely ahead" of the original hospital EBITDA case.

### [U.S. Physical Therapy Q2 2026 earnings call transcript](https://www.sec.gov/Archives/edgar/data/885978/000088597826000045/ex99-1.htm)

Executive talk · Chris Reading, Chairman and Chief Executive Officer · 2026-08-06

- CEO Chris Reading (Chairman and CEO) and interim CFO Jason Curtis presented Q2 2026: revenue $214 million (+8.5%), PT revenue $182 million (+8.4%), IIP revenue $32 million (+9.1%).
- Visits per clinic per day hit an all-time high of 33.5; record net rate of $107.59 per visit (+$2.26).
- NYU Langone affiliation: all 60 Metro clinics to transition by end of August, with about 50 clinicians hired in advance; 31 clinics integrated into hospital affiliations in Q2 and 39 more expected in Q3; Q2 hospital affiliation revenue $5.6 million.
- Mechanics: hospitals pay a per-visit fee and reimburse licensed clinical staff, which "creates nothing but upside opportunity with no cost downside".
- Headwinds: self-insured health claims about $3.2 million above last year so far; adjusted PT margin 19.9% vs 21.4%.
- Full-year 2026 adjusted EBITDA guidance of $102 million to $106 million reaffirmed; 12-clinic acquisition for $16.4 million ($12 million annual revenue); three 2026 deals total $38 million.
- Strategy: top 30 or 40 partnerships produce 75% or 80% of earnings and are candidates for hospital deals; Reading expects 2027 "to look meaningfully different"; working on digital and hybrid offerings for 2027.
- Lost one Japanese automaker IIP contract, replaced by Nissan Motor and the largest grocery chain in Texas.

## Questions about U.S. Physical Therapy, Inc.

### What does U.S. Physical Therapy do?

USPH operates outpatient physical, occupational and speech therapy clinics and home-care practices across the U.S., and provides industrial injury prevention services to employers. It had 799 clinics at 30 September 2026.

### What is U.S. Physical Therapy's revenue?

FY2025 net revenue was $781.0 million, up 16.3%. Nine-month 2026 revenue was $634.9 million, and full-year 2026 EBITDA guidance is $102 million to $106 million.

### How many employees does U.S. Physical Therapy have?

About 7,294 people at 31 December 2025, of whom about 4,200 were full-time.

### What is U.S. Physical Therapy's strategy?

It grows through clinic and IIP acquisitions, new clinics within its partnerships, and since 2026 long-term affiliations that bring its clinics into hospital systems' networks.

### Who leads U.S. Physical Therapy?

Chris Reading is Chairman and CEO; Nchacha Etta was appointed Chief Financial Officer in September 2026.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
